(Q41446013)

30 September 2017

1 reference

title

Fecal occult blood testing for colorectal cancer. Can we afford not to do this? (English)

1 reference

30 September 2017

0 references

1 reference

Bond JH

1

1 reference

30 September 2017

1 March 1997

1 reference

Gastroenterology Clinics of North America

30 September 2017

1 reference

30 September 2017

26

1 reference

30 September 2017

1

1 reference

30 September 2017

57-70

1 reference

A comparison of fecal occult-blood tests for colorectal-cancer screening

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. The Practice Parameters Committee of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Cancer of the colon, rectum, and anus: A review of 2313 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic, average-risk men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Outpatient screening for gastrointestinal lesions using guaiac-impregnated slides.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Diagnosis of Large-Bowel Cancer in the Asymptomatic Patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Occult blood testing for detection of asymptomatic colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Value of retesting subjects with a positive Hemoccult in screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Causes of Death during the First 5 Years of a Randomized Trial of Mass Screening for Colorectal Cancer with Fecal Occult Blood Test

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Cost-effectiveness model for colon cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Screening for colorectal cancer: which test is best?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Evolution of cancer of the colon and rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Small adenomas detected during fecal occult blood test screening for colorectal cancer. The impact of serendipity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

The pros and cons of fecal occult blood testing for colorectal neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Evaluation of new occult blood tests for detection of colorectal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Fecal occult blood screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Cost effectiveness of colorectal cancer screening in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Superiority of the flexible to the rigid sigmoidoscope in routine proctosigmoidoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Colorectal cancer screening comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Fecal occult blood testing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970283-1

7 January 2021

10.1016/S0889-8553(05)70283-1

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9119440